Highest category of total intake linked to increased risk for total mortality, major cardiovascular disease events, their composite
THURSDAY, Feb. 4, 2021 (HealthDay News) — A high intake of refined grains is associated with an increased risk for mortality and major cardiovascular disease events, according to a study published online Feb. 3 in The BMJ.
Sumathi Saminathan, Ph.D., from St. John’s Research Institute in Bangalore, India, and colleagues conducted a prospective cohort study in 21 countries involving 148,858 participants with a median follow-up of 9.5 years. Intakes of refined grains, whole grains, and white rice were examined, and the association with mortality, major cardiovascular disease events, and their composite was estimated. Analyses were based on data from 137,130 participants without baseline cardiovascular disease.
The researchers found that 9.2 percent of participants had a composite outcome event during follow-up. Compared with the lowest category of intake (<50 g/day), the highest category of intake of refined grains (≥350 g/day or about seven servings) was associated with an elevated risk for total mortality, major cardiovascular disease events, and their composite (hazard ratios, 1.27, 1.33, and 1.28, respectively). There were associations seen for higher intakes of refined grains with higher systolic blood pressure. Intakes of whole grains or white rice were not significantly associated with health outcomes.
“Intakes of a combination of cereal grains with a lower intake of refined wheat products should be encouraged while promoting a higher intake of whole grains,” the authors write. “Reduction in quantity and improvement in quality of carbohydrate is essential for better health outcomes.”
Several authors disclosed financial ties to the pharmaceutical industry.
Recommendations Issued for Use of Incretin-Based Meds in Pregnancy
Eating More Ultraprocessed Foods Heightens Risk for Chronic Diseases
Nutritional Deficiencies Seen in Youth Taking GLP-1 Receptor Agonists
2009 to 2023 Saw Surge in Probiotic Supplement Use
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions
High-Dose Omega-3 Linked to A-Fib Risk in Patients With High CVD Risk
Docosahexaenoic Acid Supplement Does Not Improve Cognitive Performance
Sugar-Sweetened Beverage, Fruit Juice Intake Linked to Hypertension Risk